<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AB59C39C-D551-4BCF-9AA1-1C32080BEFD5"><gtr:id>AB59C39C-D551-4BCF-9AA1-1C32080BEFD5</gtr:id><gtr:name>Zhejiang University</gtr:name><gtr:address><gtr:line1>388 Yuhangtang Road</gtr:line1><gtr:postCode>310058</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>China</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/8E860285-C7B1-4019-89F6-F94B444048BD"><gtr:id>8E860285-C7B1-4019-89F6-F94B444048BD</gtr:id><gtr:name>Ashland</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E4184B1D-6339-41F2-860A-D6E1F34AF058"><gtr:id>E4184B1D-6339-41F2-860A-D6E1F34AF058</gtr:id><gtr:name>Sympatec</gtr:name><gtr:address><gtr:line1>Bury business centre</gtr:line1><gtr:line2>Kay Street</gtr:line2><gtr:line3>Kay Street</gtr:line3><gtr:line4>Bury</gtr:line4><gtr:line5>Lancashire</gtr:line5><gtr:postCode>BL9 6BU</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/DF259B19-FD17-4588-BFEF-AD08F1193451"><gtr:id>DF259B19-FD17-4588-BFEF-AD08F1193451</gtr:id><gtr:name>De Montfort University</gtr:name><gtr:department>School of Pharmacy</gtr:department><gtr:address><gtr:line1>The Gateway</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 9BH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DF259B19-FD17-4588-BFEF-AD08F1193451"><gtr:id>DF259B19-FD17-4588-BFEF-AD08F1193451</gtr:id><gtr:name>De Montfort University</gtr:name><gtr:address><gtr:line1>The Gateway</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 9BH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AB59C39C-D551-4BCF-9AA1-1C32080BEFD5"><gtr:id>AB59C39C-D551-4BCF-9AA1-1C32080BEFD5</gtr:id><gtr:name>Zhejiang University</gtr:name><gtr:address><gtr:line1>388 Yuhangtang Road</gtr:line1><gtr:postCode>310058</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>China</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E4184B1D-6339-41F2-860A-D6E1F34AF058"><gtr:id>E4184B1D-6339-41F2-860A-D6E1F34AF058</gtr:id><gtr:name>Sympatec</gtr:name><gtr:address><gtr:line1>Bury business centre</gtr:line1><gtr:line2>Kay Street</gtr:line2><gtr:line3>Kay Street</gtr:line3><gtr:line4>Bury</gtr:line4><gtr:line5>Lancashire</gtr:line5><gtr:postCode>BL9 6BU</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8E860285-C7B1-4019-89F6-F94B444048BD"><gtr:id>8E860285-C7B1-4019-89F6-F94B444048BD</gtr:id><gtr:name>Ashland</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CAA9A40D-0226-4A4F-AC0D-D8299E30A1EF"><gtr:id>CAA9A40D-0226-4A4F-AC0D-D8299E30A1EF</gtr:id><gtr:name>Loughborough University</gtr:name><gtr:address><gtr:line1>Loughborough University</gtr:line1><gtr:line4>Loughborough</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE11 3TU</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F3F83190-ED0B-4628-9F69-6DDC50E0D323"><gtr:id>F3F83190-ED0B-4628-9F69-6DDC50E0D323</gtr:id><gtr:name>Ashland Composite Polymers</gtr:name><gtr:address><gtr:line1>Vale Industrial Estate</gtr:line1><gtr:postCode>DY11 7QP</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A57B3A1E-C5F4-43FD-812D-C5E15E87CDBD"><gtr:id>A57B3A1E-C5F4-43FD-812D-C5E15E87CDBD</gtr:id><gtr:name>Umetrics MKS AB</gtr:name><gtr:address><gtr:line1>Tvistev?gen 48</gtr:line1><gtr:line2>(Uminova Science Park</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CBC867FA-50F0-44FB-A9EC-39ABBFA28300"><gtr:id>CBC867FA-50F0-44FB-A9EC-39ABBFA28300</gtr:id><gtr:name>GenVolt Ltd</gtr:name><gtr:address><gtr:line1>New Road</gtr:line1><gtr:line2>Highley</gtr:line2><gtr:line3>Bridgnorth</gtr:line3><gtr:postCode>WV16 6NN</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CDD64036-C7C4-4924-8321-6076FB363042"><gtr:id>CDD64036-C7C4-4924-8321-6076FB363042</gtr:id><gtr:name>University of Sunderland</gtr:name><gtr:address><gtr:line1>Floor 2</gtr:line1><gtr:line2>Edinburgh Building</gtr:line2><gtr:line3>Chester Road</gtr:line3><gtr:line4>Sunderland</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>SR1   3SD</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/0EF4447C-DB44-40E5-868B-54E0D460C952"><gtr:id>0EF4447C-DB44-40E5-868B-54E0D460C952</gtr:id><gtr:name>Rotronic Intruments (UK) Ltd</gtr:name><gtr:address><gtr:line1>Crompton Fields</gtr:line1><gtr:line2>Crompton Way</gtr:line2><gtr:line3>Crawley</gtr:line3><gtr:postCode>RH10 9EE</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EAAD4D43-BD15-432B-9385-2DBD0C65958D"><gtr:id>EAAD4D43-BD15-432B-9385-2DBD0C65958D</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>University of Bath</gtr:line1><gtr:line2>Claverton Down</gtr:line2><gtr:line4>Bath</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/955C55E8-783E-4842-BB2C-2D275A3CAF82"><gtr:id>955C55E8-783E-4842-BB2C-2D275A3CAF82</gtr:id><gtr:name>University of Portsmouth</gtr:name><gtr:address><gtr:line1>University House</gtr:line1><gtr:line2>Winston Churchill Avenue</gtr:line2><gtr:line4>Portsmouth</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>PO1 2UP</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DF0020F8-9212-4670-ADC0-CBDFF5B93548"><gtr:id>DF0020F8-9212-4670-ADC0-CBDFF5B93548</gtr:id><gtr:name>GlaxoSmithKline</gtr:name><gtr:address><gtr:line1>Stockley Park West</gtr:line1><gtr:line4>Uxbridge</gtr:line4><gtr:postCode>UB11 1BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/16B66DF2-0DB8-497B-B631-E3AB231A61EB"><gtr:id>16B66DF2-0DB8-497B-B631-E3AB231A61EB</gtr:id><gtr:name>BlueFrog Design</gtr:name><gtr:address><gtr:line1>19 St Margarets Street</gtr:line1><gtr:line2>Leicester</gtr:line2><gtr:postCode>LE1 3EB</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/67B34D05-3A52-4A09-8FF9-F2398D60E246"><gtr:id>67B34D05-3A52-4A09-8FF9-F2398D60E246</gtr:id><gtr:name>University of Surrey</gtr:name><gtr:address><gtr:line1>Registry</gtr:line1><gtr:line2>Stag Hill</gtr:line2><gtr:line4>Guildford</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>GU2 7XH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/125DD984-A1FD-46AF-A3ED-2802149ABD18"><gtr:id>125DD984-A1FD-46AF-A3ED-2802149ABD18</gtr:id><gtr:name>VolitionRX</gtr:name><gtr:address><gtr:line1>20A Rue De Seminaire</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/71269740-3FA7-4F16-8993-095E5EA21D07"><gtr:id>71269740-3FA7-4F16-8993-095E5EA21D07</gtr:id><gtr:name>OncoLytika</gtr:name><gtr:address><gtr:line1>1 The Firs</gtr:line1><gtr:line2>Wilburton</gtr:line2><gtr:postCode>CB6 3FL</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/18DBF684-FCC0-4363-84CF-585FA60CAD53"><gtr:id>18DBF684-FCC0-4363-84CF-585FA60CAD53</gtr:id><gtr:name>GEA Pharma Systems Ltd</gtr:name><gtr:address><gtr:line1>PO Box 15</gtr:line1><gtr:line2>Chandlers Ford</gtr:line2><gtr:postCode>SO53 4ZD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D9A93A23-5B9D-473E-8D4F-80E344F5D678"><gtr:id>D9A93A23-5B9D-473E-8D4F-80E344F5D678</gtr:id><gtr:firstName>Mohan</gtr:firstName><gtr:surname>Edirisinghe</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6E7A6D1E-87DB-49D0-BC1F-F8E9B6E3DE41"><gtr:id>6E7A6D1E-87DB-49D0-BC1F-F8E9B6E3DE41</gtr:id><gtr:firstName>Zeeshan</gtr:firstName><gtr:surname>Ahmad</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=EP%2FN006399%2F1"><gtr:id>72201631-A9F4-4A8E-A267-A3F32852BBE9</gtr:id><gtr:title>EHDA Network-Pharmaceutical EHDA Technology: Developing QbD Facilitated, Continuous and Scaled Therapy Enabling Platforms</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/N006399/1</gtr:grantReference><gtr:abstractText>Advances in fit for use manufacturing of biopharmaceutical drug delivery and pharmaceutical systems are now required to fit Quality by Design (QbD) models. These current regulations require excellence to be built into the preparation of emerging products (both material and process) thereby leading to product robustness and quality. In addition, industrial needs (economical and reproducible quality enhancement) are driving manufacturing towards continuous processes over batch type processes which also rely on QbD (for integrity and quality). EHDA technology is a robust process that has been utilised in various formats (e.g. electrospinning, electrospraying, bubbling and even 3D printing) and is favourable due to applicability with the development of stable nanomedicines and biopharmaceuticals, the emergence of this technology is clearly evident in the UK and on the global scale. Attempts in scaling up (for suitable pharmaceutical scale) and in tandem with continuous processes (including controlled manufacturing) have been very limited. There also, now, remains a huge void in the adaptation of sensible QbD (multi-variate) for the current methods developed and also those required by industry. While lab scale research continues with the ongoing development of such processes (e.g. nanomedicines, smart and controlled delivery), the transition to industry or the clinic will have to meet these regulations (and scales) for there to be a real impact, which is now, also, an important aspect of grass root research in the UK.

The EHDA network brings together specialists from academia and industry to advance this technology through several means. Firstly, initiating developments towards a real-viable scale for Pharmaceutical production. Secondly, to incorporate developments in lean manufacturing and legislation (e.g. continuous manufacturing, online diagnostics, QbD and adaptable scale). Thirdly, to marry optimised lean technologies with novel and emerging macromolecular therapies and actives. The network has a wide range of activities and initiatives which will lead to significant developments (and collaborations) in an area of increasing global interest (EHDA processes) - but currently only on a viable lab scale to date. This network will be the first of its kind and will serve as the central and pioneering hub in this remit.</gtr:abstractText><gtr:potentialImpactText>This EHDA network will give rise to several initiatives (QbD, continuous processing and scale-up) which are meeting the needs of industrial manufacturing and much needed improved and novel therapeutic delivery. EHDA technologies already present desirable options in ambient condition preparation of pharmaceuticals, non-destructive preparation of biopharmaceutics (especially macromolecules) due to low energy processes, controlled encapsulation (layering, compartmentalisation and multi-coating thickness control on the nano and micron scales). In addition, improving solubility of emerging active chemicals (most of them poorly soluble) and offering morphological variations (fibres, particles, bubbles, capsules etc) while maintaining the aforementioned properties are also key factors for industry. Combining all these benefits will therefore significantly improve drug delivery science as well as reducing overall manufacturing costs, increasing efficiency, bringing new technologies to suitable production rates and meeting regulatory needs for impact case fruition (see letters of support from GSK, GEA Pharma, VolitionRX, Oncalytica and UCL-EMT).The impact of this work will also be crucial to pharmacists, pharmaceutical industries and scientists and the public in general, although other industries will also benefit where precision control on manufacturing is highly desirable.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-10-29</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2015-10-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>169320</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ashland</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Ashland Speciality Ingredients</gtr:department><gtr:description>De Montfort University (Zeeshan Ahmad) and Ashland Specialist Ingredients</gtr:description><gtr:id>D2BF0880-081C-4519-80CA-42DA1313D924</gtr:id><gtr:impact>This project is only underway</gtr:impact><gtr:partnerContribution>New Polymeric Materials and expertise in polymer design for drug delivery</gtr:partnerContribution><gtr:piContribution>Application of QbD Models and EHDA Engineering Techniques</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sympatec</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>De Montfort University and SympaTech</gtr:description><gtr:id>66B8F939-B944-4F6D-96E4-B478F42144BA</gtr:id><gtr:impact>THis has just been initiated</gtr:impact><gtr:partnerContribution>Development and advanced analysis of live sizing</gtr:partnerContribution><gtr:piContribution>Utilising EHDA Technology to fit into the sizing process</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Zhejiang University</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>De Montfort University and Zhejiang University</gtr:description><gtr:id>3EE39D00-0977-4DD6-A236-3362C16F98DD</gtr:id><gtr:impact>Data has been generated through inkind support and collaborative research. There is an expectation to publish two articles.There is also a view to apply for funding where both partners can benefit.</gtr:impact><gtr:partnerContribution>Expertise in EHDA with a focus on mechanical propsects</gtr:partnerContribution><gtr:piContribution>Expertise in EHDA with a focus on Pharmaceutical Engineering</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>International Networking and Collaborative Provision</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5AE43A79-AB26-40EF-B97E-C442834D7A93</gtr:id><gtr:impact>While the network covers key players in the UK (and we have also engaged pioneers in related fields in the UK too); this activity provides an opportunity to work with internationally leading researchers in drug delivery, pharmaceutics and technologies. We have had a positive response to date and this will further market our network and hopefully extend its outputs and acceptance. Furthermore, these collaborative fronts provide potential publication, funding and technological enchantment opportunities.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International dissemination</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9914E8CA-1270-4544-8709-CF413593FA93</gtr:id><gtr:impact>Research around EHDA Technologies, sister (advanced merged) technologies and the efforts of the EHDA Network are being disseminated across UK, EU and Globally. This is being done through conferences, seminars and workshops. Conferences are wide reaching (pharmaceutical, materials, nanotechnologies, patient group driven, pharmacological) since our network has a broad coverage and expertise. We also have QbD (legislative), industrial and academic angles providing several points for contact. This provides collaborate provision through numerous themes. Network partners (and their students) are involved as we plan for long term impact for technological development, currently at the early stage</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cross Institute Exploratory Research For Technology Enhancement</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DFDFD2F0-3971-4B9B-B1AB-01AE33D09428</gtr:id><gtr:impact>Students (post-graduate) and/or academics undertake exploratory research based on network partner discussions. This includes visiting other laboratories on the network and also visiting some International research groups. There is also utilisation of technologies not accessible at their own location. Data generated will assist towards further work development and also possibly research manuscripts</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research and Technological Engagement with the Academy of Pharmaceutical Sciences UK -Recognition</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4CC2AB26-40B5-4952-A0B4-51B3CD0D18AD</gtr:id><gtr:impact>The Academy of Pharmaceutical Sciences (APS) is the main organisation for Pharmaceutical Research in the UK. We have successfully persuaded them to include our efforts in EHDA to be represented alongside the well-established and emerging processes. We now have dedicated sessions at the APS and infact they were impressed to see the EHDA Network support part of the &amp;gt;15 posters at this event. They have also provided a provision for this on their web-pages for future events.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EPSRC EHDA Network International Conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C817E267-F521-44DF-9FA2-A2ED8C13F193</gtr:id><gtr:impact>We organised this event and invited pioneers in the UK from several areas and also world-leading specialists who are Editors of top journals in the field and International prize winners. All those in the UK from students to established academics appreciated this. More importantly, very interesting discussions pursued with International speakers who were enlightened about the technology. Some of these speakers are seeking collaborative provision and have invited us to visit their laboratories- as expected.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Network Special Issue in AAPSPharmSciTech Journal entailing EHDA Technology and General Emerging Pharm Tech Structure Theme</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>315F2D82-C041-4B2D-89B2-D613A0B668E5</gtr:id><gtr:impact>A special issue was agreed by the Editor in Chief, Prof. Bill Williams, Texas and was part of the EPSRC EHDA Networks strategic plan.
The thematic issue is co-edited by Prof. Z Ahmad and Prof. M Edirisinghe and was based around Nano and Microstructures which essentially covers EHDA technologies but also brings other technologies into the fold, especially those already accepted and well known. 
Ten articles have been published in the journal and the opening session acknowledges support. There is broad readership for the AAPSPharmSciTech Journal, which is part of the prestigious AAPS series. We also state that six articles have come from the EHDA Networks project partners which has increased our own capacity and outcomes. We also now begin to include EHDA Technologies in the same breath as existing technologies for researchers, industrialists and all others involved with emerging medicinal technologies.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Engagement of early career researchers (ECRs) in leading events</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EB0F23EE-8306-4174-8542-5740549D1B9A</gtr:id><gtr:impact>Involving early career researchers (ECR's) at networking events taking key roles (opening sessions and leading discussions) has provided them with recognition amongst their peers and other senior academics on the network. This also provides ECRs a chance to develop their skills and engage with experts in the field</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Project Partner Meetings Between Multiple Specialists from Industry and Academia - Knowledge Advance and Technological Enhancement (including those from EU)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>57295E9C-DDDC-44DB-B5F8-C69E764441E4</gtr:id><gtr:impact>Detailed Discussions between Academics and Industrialists on pre-designed work packets bringing specific expertise to the research group. In addition this provided further discussion and off-shoots for exploratory research and collaborative provision. Industry engaged fully with EHDA techniques showing keen interest</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Academic-Industry experimental explorations</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>309ED752-15B9-4403-B9D6-9D5E8DC0DC6C</gtr:id><gtr:impact>Getting industrial involvement is crucial to take EHDA Technologies further. Academics are interacting with industries at network meetings and then also trying to establish common ground between technologies and industrial interests for further advances. Industries are also understanding EHDA technologies a lot more and the benefits these can bring to current medication and as other therapies. Industries have important specialisms and have realised there is good reason to take such developments further. Industries supporting the research with inkind support.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Regular Steering Group Committee Meetings (De Montfort University) with the APS on Materials Science and Process Technologies and Manufacturing</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6DCAA4D8-1865-4343-A75E-3FF2B7E2FF5C</gtr:id><gtr:impact>We have managed to persuade two of the APS focus groups to accept the benefits and emergence of EHDA technologies. We continue to work with the APS focus groups and we are now part of regular discussion at the bi-monthly meetings. We look forward to moving forward .</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>118000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society Industry Fellowship with BlueFrog Design</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>59FA2320-89D1-4CA6-9A8E-72F367369DD5</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DMU PhD Scholarships</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>De Montfort University</gtr:fundingOrg><gtr:id>3FE9F260-FE43-42D4-9FE1-30C4DD3FC2DC</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The project started on 01st Nov. 2015, and is in progress at present. The Network has been created and a first meeting of the network group (10 industrial partners and 12 academic institutions) has just taken place and its actions are being implemented.</gtr:description><gtr:firstYearOfImpact>2015</gtr:firstYearOfImpact><gtr:id>0D8290C0-040F-4047-A083-7FABEA7227FF</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:sector>Chemicals,Education,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The setting up of this network has allowed the industry and academia to have a common platform in an emerging technology (electrohydrodynamic atomisation forming) vital to the pharmaceutical industry.</gtr:description><gtr:exploitationPathways>This network will help industries to be up dated on the latest electrohydrodynamic technology and tools which will help them to improve the diversity of their products and also start up new ventures.</gtr:exploitationPathways><gtr:id>D92433A5-B176-43D0-8856-BE8F01D5407E</gtr:id><gtr:sectors><gtr:sector>Chemicals,Creative Economy,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0518A22E-637E-4606-8267-4FC88FF88230"><gtr:id>0518A22E-637E-4606-8267-4FC88FF88230</gtr:id><gtr:title>Pharmaceutical and biomaterial engineering via electrohydrodynamic atomization technologies.</gtr:title><gtr:parentPublicationTitle>Drug discovery today</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/877d8c3e4251f36664616b58182ca8a2"><gtr:id>877d8c3e4251f36664616b58182ca8a2</gtr:id><gtr:otherNames>Mehta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1359-6446</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/N006399/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>